{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T18:52:14Z","timestamp":1773168734240,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T00:00:00Z","timestamp":1554163200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","valueinhealthjournal.com","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.jval.2017.08.3017","type":"journal-article","created":{"date-parts":[[2017,11,7]],"date-time":"2017-11-07T19:46:16Z","timestamp":1510083976000},"page":"441-448","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The CDI-DaySyms: Content Development of a New Patient-Reported Outcome Questionnaire for Symptoms of Clostridium difficile Infection"],"prefix":"10.1016","volume":"21","author":[{"given":"Leah","family":"Kleinman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George H.","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elke","family":"Hunsche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9","family":"Sch\u00fcler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl Erik","family":"Nord","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.jval.2017.08.3017_bib1","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1093\/cid\/cis319","article-title":"Current status of Clostridium difficile infection epidemiology","volume":"55","author":"Lessa","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jval.2017.08.3017_bib2","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/651706","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)","volume":"31","author":"Cohen","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jval.2017.08.3017_bib3","first-page":"10","article-title":"Using the lived experiences of patients with Clostridium difficile infection to improve care","volume":"106","author":"Madeo","year":"2010","journal-title":"Nurs Times"},{"issue":"Suppl. 2","key":"10.1016\/j.jval.2017.08.3017_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12418","article-title":"European Society of Clinical Microbiology and Infectious Diseases. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection","volume":"20","author":"Debast","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl. 2","key":"10.1016\/j.jval.2017.08.3017_bib5","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1093\/cid\/civ140","article-title":"Current trends in the epidemiology and outcomes of Clostridium difficile infection","volume":"60","author":"Evans","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jval.2017.08.3017_bib6","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.jval.2013.08.2293","article-title":"Assessment of PRO label claims granted by the FDA as compared to the EMA (2006\u20132010)","volume":"16","author":"DeMuro","year":"2013","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2017.08.3017_bib7","unstructured":"US Food and Drug Administration. Guidance for industry. Patient-reported outcome measures: use in medical product development to support labeling claims. Available from: http:\/\/www.fda.gov\/downloads\/Drugs\/Guidances\/UCM193282.pdf. [Accessed January 20, 2016]."},{"key":"10.1016\/j.jval.2017.08.3017_bib8","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jval.2011.06.014","article-title":"Content validity\u2014establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force Report, Part 1\u2014eliciting concepts for a new PRO instrument","volume":"14","author":"Patrick","year":"2011","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2017.08.3017_bib9","unstructured":"US Food and Drug Administration. Roadmap to patient-focused outcome measurement in clinical trials. Available from: http:\/\/www.fda.gov\/Drugs\/DevelopmentApprovalProcess\/DrugDevelopmentToolsQualificationProgram\/ucm370177.htm. [Accessed January 23, 2016]."},{"key":"10.1016\/j.jval.2017.08.3017_bib10","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jval.2015.08.006","article-title":"Clinical outcome assessments: conceptual foundation\u2014report of the ISPOR Clinical Outcomes Assessment\u2014Emerging Good Practices for Outcomes Research Task Force","volume":"18","author":"Walton","year":"2015","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2017.08.3017_bib11","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jval.2011.06.013","article-title":"Content validity\u2014establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force Report, part 2\u2014assessing respondent understanding","volume":"14","author":"Patrick","year":"2011","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2017.08.3017_bib12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2165\/00019053-200826050-00002","article-title":"Perspectives on patient-reported outcomes: content validity and qualitative research in a changing clinical trial environment","volume":"26","author":"Leidy","year":"2008","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jval.2017.08.3017_bib13","first-page":"1","article-title":"Writing good at a seventh-grade reading level","volume":"2","author":"Goldfarb","year":"2006","journal-title":"J Clin Res Best Pract"},{"key":"10.1016\/j.jval.2017.08.3017_bib14","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s11136-009-9496-9","article-title":"Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items","volume":"18","author":"Hays","year":"2009","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jval.2017.08.3017_bib15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF01535722","article-title":"GSRS\u2014a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease","volume":"33","author":"Svedlund","year":"1988","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jval.2017.08.3017_bib16","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/0016-5085(89)90905-0","article-title":"A new measure of health status for clinical trials in inflammatory bowel disease","volume":"96","author":"Guyatt","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jval.2017.08.3017_bib17","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1097\/00005176-199904001-00003","article-title":"Development and subsequent refinement of the inflammatory bowel disease questionnaire: a quality-of-life instrument for adult patients with inflammatory bowel disease","volume":"28","author":"Irvine","year":"1999","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jval.2017.08.3017_bib18","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/j.1572-0241.2002.05616.x","article-title":"The IBS-36: a new quality of life measure for irritable bowel syndrome","volume":"97","author":"Groll","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jval.2017.08.3017_bib19","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1046\/j.1365-2036.1998.00399.x","article-title":"Development of a digestive health status instrument: tests of scaling assumptions, structure and reliability in a primary care population","volume":"12","author":"Shaw","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jval.2017.08.3017_bib20","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ijid.2015.06.007","article-title":"Emergence of community-acquired Clostridium difficile infection: the experience of a French hospital and review of the literature","volume":"37","author":"Ogielska","year":"2015","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jval.2017.08.3017_bib21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3201\/eid1602.090953","article-title":"Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USA","volume":"16","author":"Kutty","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jval.2017.08.3017_bib22","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1086\/605719","article-title":"Population-based surveillance of Clostridium difficile infection in Manitoba, Canada, by using interim surveillance definitions","volume":"30","author":"Lambert","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jval.2017.08.3017_bib23","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/jac\/dkn163","article-title":"A case-control study of community-associated Clostridium difficile infection","volume":"62","author":"Wilcox","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jval.2017.08.3017_bib24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/ajg.2011.398","article-title":"The epidemiology of community-acquired Clostridium difficile infection: a population-based study","volume":"107","author":"Khanna","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jval.2017.08.3017_bib25","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2188\/jea.6.192","article-title":"Choice of response scale for health measurement: comparison of 4, 5, and 7-point scales and visual analog scale","volume":"6","author":"Nagata","year":"1996","journal-title":"J Epidemiol"},{"key":"10.1016\/j.jval.2017.08.3017_bib26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3949\/ccjm.73.2.187","article-title":"Clostridium difficile-associated disease: new challenges from an established pathogen","volume":"73","author":"Sunenshine","year":"2006","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.jval.2017.08.3017_bib27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1017\/ice.2014.8","article-title":"Postoperative burden of hospital-acquired Clostridium difficile infection","volume":"36","author":"Abdelsattar","year":"2015","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jval.2017.08.3017_bib28","doi-asserted-by":"crossref","first-page":"ofv196","DOI":"10.1093\/ofid\/ofv196","article-title":"Burden of nursing home-onset Clostridium difficile infection in the United States: estimates of incidence and patient outcomes.","volume":"3","author":"Hunter","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jval.2017.08.3017_bib29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.idc.2014.11.003","article-title":"The morbidity, mortality, and costs associated with Clostridium difficile infection","volume":"29","author":"Kwon","year":"2015","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.jval.2017.08.3017_bib30","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s40271-013-0043-y","article-title":"Patients\u2019 experience and perception of hospital-treated Clostridium difficile infections: a qualitative study","volume":"7","author":"Guillemin","year":"2014","journal-title":"Patient"},{"key":"10.1016\/j.jval.2017.08.3017_bib31","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/MCG.0000000000000473","article-title":"Development and validation of a Clostridium difficile health-related quality-of-life questionnaire","volume":"50","author":"Garey","year":"2016","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jval.2017.08.3017_bib32","doi-asserted-by":"crossref","first-page":"ofu048","DOI":"10.1093\/ofid\/ofu048","article-title":"Determinants of Clostridium difficile infection incidence across diverse United States geographic locations","volume":"1","author":"Lessa","year":"2014","journal-title":"Open Forum Infect Dis"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109830151733351X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109830151733351X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T21:56:34Z","timestamp":1554155794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109830151733351X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S109830151733351X"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2017.08.3017","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The CDI-DaySyms: Content Development of a New Patient-Reported Outcome Questionnaire for Symptoms of Clostridium difficile Infection","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2017.08.3017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}